89 related articles for article (PubMed ID: 2913597)
1. Vomiting, chemoreceptor trigger zone, and dopamine.
Shen WW
Psychosomatics; 1989; 30(1):118-9. PubMed ID: 2913597
[No Abstract] [Full Text] [Related]
2. Amoxapine treatment of psychogenic vomiting and depression.
Golden RN; Janke I; Haggerty JJ
Psychosomatics; 1988; 29(3):352-4. PubMed ID: 3406355
[No Abstract] [Full Text] [Related]
3. Efficacy of amoxapine in psychotic depression.
Anton RF; Sexauer JD
Am J Psychiatry; 1983 Oct; 140(10):1344-7. PubMed ID: 6624968
[TBL] [Abstract][Full Text] [Related]
4. Amoxapine elevates serum prolactin in depressed men.
Anton RF; Sexauer JD; Randall CL
J Affect Disord; 1983 Nov; 5(4):305-10. PubMed ID: 6229562
[TBL] [Abstract][Full Text] [Related]
5. Relapse on amoxapine.
Sedler MJ
J Clin Psychiatry; 1983 Feb; 44(2):81-2. PubMed ID: 6826537
[No Abstract] [Full Text] [Related]
6. Amoxapine in psychotic-delusional depression.
Ragheb M; Ban TA
Am J Psychiatry; 1984 Oct; 141(10):1312-3. PubMed ID: 6486282
[No Abstract] [Full Text] [Related]
7. Tolerance to amoxapine antidepressant effects.
Zetin M; Aden G; Moldawsky R
Clin Ther; 1983; 5(6):638-43. PubMed ID: 6627290
[TBL] [Abstract][Full Text] [Related]
8. Experience with a new rapid-acting antidepressant: amoxapine.
Cancro R
Adv Biochem Psychopharmacol; 1982; 32():121-4. PubMed ID: 7090890
[No Abstract] [Full Text] [Related]
9. [Moxadil].
Peutillot JF; Peutillot A
Soins Psychiatr; 1984 Oct; (48):I-II. PubMed ID: 6569711
[No Abstract] [Full Text] [Related]
10. Dopamine receptor supersensitivity and the chemoreceptor trigger zone.
Shen WW; Baig MS; Sata LS; Hofstatter L
Biol Psychiatry; 1983 Aug; 18(8):917-21. PubMed ID: 6615947
[No Abstract] [Full Text] [Related]
11. Amoxapine failure--a neuroleptic property?
Signer SF; Billings RF
Can J Psychiatry; 1984 Oct; 29(6):510-2. PubMed ID: 6149011
[TBL] [Abstract][Full Text] [Related]
12. A critical appraisal of amoxapine.
Smith RS; Ayd FJ
J Clin Psychiatry; 1981 Jun; 42(6):238-42. PubMed ID: 7240104
[TBL] [Abstract][Full Text] [Related]
13. Effect of amoxapine on speech in a patient with Huntington's disease.
Moldawsky RJ
Am J Psychiatry; 1984 Jan; 141(1):150. PubMed ID: 6229184
[No Abstract] [Full Text] [Related]
14. A follow-up report and double blind comparative study of amoxapine and imipramine for the treatment of depressive inpatients.
Eilenberg MD
N Z Med J; 1982 Mar; 95(704):189-91. PubMed ID: 7045745
[No Abstract] [Full Text] [Related]
15. Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
Robertson AG; Berry R; Meltzer HY
Psychopharmacology (Berl); 1982; 78(3):287-92. PubMed ID: 6818584
[TBL] [Abstract][Full Text] [Related]
16. Delusional hypochondriasis, depression, and amoxapine.
Tollefson G
Am J Psychiatry; 1985 Dec; 142(12):1518-9. PubMed ID: 4073329
[No Abstract] [Full Text] [Related]
17. Amoxapine and amitriptyline in the outpatient treatment of endogenous depression.
Donlon PT; Biertuemphel H; Willenbring M
J Clin Psychiatry; 1981 Jan; 42(1):11-5. PubMed ID: 7007357
[TBL] [Abstract][Full Text] [Related]
18. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
Fabre LF
J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
[TBL] [Abstract][Full Text] [Related]
19. A double-blind comparative clinical study of amoxapine and amitriptyline in depressed, hospitalised patients.
James B
N Z Med J; 1982 Jun; 95(709):391-3. PubMed ID: 7050783
[TBL] [Abstract][Full Text] [Related]
20. Tricyclic antidepressant use in a patient with bundle branch blocks and ventricular ectopy.
Vieweg WV; Yazel JJ; Ballenger JC
J Clin Psychiatry; 1984 Aug; 45(8):353-5. PubMed ID: 6204970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
